{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:47:04Z","timestamp":1785689224292,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CORPG3L0331"],"award-info":[{"award-number":["CORPG3L0331"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1245\/s10434-024-15460-0","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:02:31Z","timestamp":1716469351000},"page":"6628-6634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?"],"prefix":"10.1245","volume":"31","author":[{"given":"Tzu-Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ju","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-8783","authenticated-orcid":false,"given":"Yin-Kai","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"3","key":"15460_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.asjsur.2016.10.005","volume":"41","author":"FL Huang","year":"2018","unstructured":"Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210\u20135.","journal-title":"Asian J Surg"},{"issue":"7","key":"15460_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/0218492318797228","volume":"26","author":"LP Depypere","year":"2018","unstructured":"Depypere LP, Moons J, Lerut TE, Coosemans W, Van Veer H, Nafteux PR. Palliative esophagectomy in unexpected metastatic disease: sense or nonsense? Asian Cardiovasc Thorac Ann. 2018;26(7):552\u20137.","journal-title":"Asian Cardiovasc Thorac Ann."},{"issue":"11","key":"15460_CR3","first-page":"CD004063","volume":"11","author":"VT Janmaat","year":"2017","unstructured":"Janmaat VT, Steyerberg EW, van der Gaast A, et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11(11):CD004063.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10110","key":"15460_CR4","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","volume":"390","author":"J Lagergren","year":"2017","unstructured":"Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet (London, England). 2017;390(10110):2383\u201396.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"15460_CR5","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.21873\/anticanres.13392","volume":"39","author":"A Tamagawa","year":"2019","unstructured":"Tamagawa A, Aoyama T, Tamagawa H, et al. Influence of postoperative pneumonia on esophageal cancer survival and recurrence. Anticancer Res. 2019;39(5):2671\u20138.","journal-title":"Anticancer Res"},{"issue":"2","key":"15460_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/SLA.0000000000001098","volume":"262","author":"DE Low","year":"2015","unstructured":"Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg. 2015;262(2):286\u201394.","journal-title":"Ann Surg"},{"issue":"6","key":"15460_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.35772\/ghm.2020.01090","volume":"3","author":"K Yamada","year":"2021","unstructured":"Yamada K, Nohara K, Enomoto N, et al. Surgical strategies for treatment of clinical T4 esophageal cancer in Japan. Glob Health Med. 2021;3(6):371\u20137.","journal-title":"Glob Health Med"},{"issue":"2","key":"15460_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/dote\/9.2.117","volume":"9","author":"\u00d6 Horv\u00e1th","year":"1996","unstructured":"Horv\u00e1th \u00d6, Lukacs L. Palliation of esophageal cancer: palliative resection and bypass surgery. Dis Esophagus. 1996;9(2):117\u201322.","journal-title":"Dis Esophagus"},{"key":"15460_CR9","doi-asserted-by":"publisher","DOI":"10.1159\/000533772","author":"T Sugase","year":"2023","unstructured":"Sugase T, Kanemura T, Takeoka T, et al. Clinicopathological characteristics and survival outcomes in patients with advanced esophageal squamous cell carcinoma who were intraoperatively diagnosed non-curative. Oncology. 2023. https:\/\/doi.org\/10.1159\/000533772.","journal-title":"Oncology"},{"issue":"1","key":"15460_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00423-023-02940-2","volume":"408","author":"Y Fujii","year":"2023","unstructured":"Fujii Y, Daiko H, Kubo K, et al. Non-curative resection for surgical T4b esophageal cancer: esophagectomy or non-esophagectomy? Langenbecks Arch Surg. 2023;408(1):201.","journal-title":"Langenbecks Arch Surg"},{"issue":"5","key":"15460_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0002-9610(01)00763-2","volume":"182","author":"JD Urschel","year":"2001","unstructured":"Urschel JD, Urschel DM, Miller JD, Bennett WF, Young JE. A meta-analysis of randomized controlled trials of route of reconstruction after esophagectomy for cancer. Am J Surg. 2001;182(5):470\u20135.","journal-title":"Am J Surg"},{"issue":"2","key":"15460_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jss.2015.11.030","volume":"201","author":"J Yang","year":"2016","unstructured":"Yang J, Xu C, Lian D, et al. Esophageal reconstruction: posterior mediastinal or retrosternal route. J Surg Res. 2016;201(2):364\u20139.","journal-title":"J Surg Res"},{"issue":"3","key":"15460_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000070387","volume":"20","author":"AC Wong","year":"2003","unstructured":"Wong AC, Law S, Wong J. Influence of the route of reconstruction on morbidity, mortality and local recurrence after esophagectomy for cancer. Dig Surg. 2003;20(3):209\u201314.","journal-title":"Dig Surg"},{"issue":"10","key":"15460_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2217\/fon-2018-0609","volume":"15","author":"K Kato","year":"2019","unstructured":"Kato K, Shah MA, Enzinger P, et al. KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer. Future Oncol (London, England). 2019;15(10):1057\u201366.","journal-title":"Future Oncol (London, England)."},{"issue":"5","key":"15460_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki Y, Ajani JA, Kato K, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. New Engl J Med. 2022;386(5):449\u201362.","journal-title":"New Engl J Med"},{"issue":"11","key":"15460_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","volume":"20","author":"K Kato","year":"2019","unstructured":"Kato K, Cho BC, Takahashi M, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20(11):1506\u201317.","journal-title":"Lancet Oncol"},{"issue":"35","key":"15460_CR17","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1200\/JCO.20.01888","volume":"38","author":"T Kojima","year":"2020","unstructured":"Kojima T, Shah MA, Muro K, et al. Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer. J Clin Oncol. 2020;38(35):4138\u201348.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15460-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15460-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T14:22:50Z","timestamp":1726755770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15460-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["15460"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15460-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tzu-Yi Yang, Chi-Ju Yeh, MD, Chien-Hung Chiu, and Yin-Kai Chao declare they have no conflicts of interest that may be relevant to the contents of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}